We suggest that the aberrant expression and splicing of erythroid-related genes observed in the CD34+ cells of MDS patients with SF3B1 mutation may have a role in the ineffective erythropoiesis found in these patients. This evidence concerns the gene CD34 and myelodysplastic syndrome.